Ещё 14
Править ссылки
Эта страница в последний раз была отредактирована 17 сентября 2020 в 07:34.
Текст доступен по лицензии Creative Commons Attribution-ShareAlike; в отдельных случаях могут действовать дополнительные условия. Подробнее см. Условия использования.
Wikipedia® — зарегистрированный товарный знак некоммерческой организации Wikimedia Foundation, Inc.

Vinblastine (VBL), sold under the brand name Velban among others, is a chemotherapy medication, typically used with other medications, to treat a number of types of cancer.[1] This includes Hodgkin's lymphoma, non-small cell lung cancer, bladder cancer, brain cancer, melanoma, and testicular cancer.[1] It is given by injection into a vein.[1]
Most people experience some side effects.[1] Commonly it causes a change in sensation, constipation, weakness, loss of appetite, and headaches.[1] Severe side effects include low blood cell counts and shortness of breath.[1] It should not be given to people who have a current bacterial infection.[1] Use during pregnancy will likely harm the baby.[1] Vinblastine works by blocking cell division.[1]
Vinblastine was isolated in 1958.[2] An example of a natural herbal remedy that has since been developed into a conventional medicine, vinblastine was originally obtained from the Madagascar periwinkle.[3] It is on the World Health Organization's List of Essential Medicines.[4]
Contents
1Medical uses
2Side effects
3Pharmacology
4Mechanism of action
5Isolation and synthesis
6History
7References
8External links
Medical uses[edit]
Vinblastine is a component of a number of chemotherapy regimens, including ABVD for Hodgkin lymphoma. It is also used to treat histiocytosis according to the established protocols of the Histiocytosis Association.
Side effects[edit]
Adverse effects of vinblastine include hair loss, loss of white blood cells and blood platelets, gastrointestinal problems, high blood pressure, excessive sweating, depression, muscle cramps, vertigo and headaches.[5][1]
Pharmacology[edit]
Vinblastine is a vinca alkaloid[6][2][7] and a chemical analogue of vincristine.[8][9] It binds tubulin, thereby inhibiting the assembly of microtubules.[10] Vinblastine treatment causes M phase specific cell cycle arrest by disrupting microtubule assembly and proper formation of the mitotic spindle and the kinetochore, each of which are necessary for the separation of chromosomes during anaphase of mitosis. Toxicities include bone marrow suppression (which is dose-limiting), gastrointestinal toxicity, potent vesicant (blister-forming) activity, and extravasation injury (forms deep ulcers). Vinblastine paracrystals may be composed of tightly-packed unpolymerized tubulin or microtubules.[11]
Vinblastine is reported to be an effective component of certain chemotherapy regimens, particularly when used with bleomycin, and methotrexate in VBM chemotherapy for Stage IA or IIA Hodgkin lymphomas. The inclusion of vinblastine allows for lower doses of bleomycin and reduced overall toxicity with larger resting periods between chemotherapy cycles.[12]
Mechanism of action[edit]
📷
The complex of tubulin and vinblastine. Vinblastine is shown in yellow.
Microtubule-disruptive drugs like vinblastine, colcemid, and nocodazole have been reported to act by two mechanisms.[13] At very low concentrations they suppress microtubule dynamics and at higher concentrations they reduce microtubule polymer mass. Recent findings indicate that they also produce microtubule fragments by stimulating microtubule minus-end detachment from their organizing centers. Dose-response studies further indicate that enhanced microtubule detachment from spindle poles correlate best with cytotoxicity.[14]
Isolation and synthesis[edit]
Vinblastine may be isolated from the Madagascar Periwinkle (Catharanthus roseus), along with several of its precursors, catharanthine and vindoline. Extraction is costly and yields of vinblastine and its precursors are low, although procedures for rapid isolation with improved yields avoiding auto-oxidation have been developed. Enantioselective synthesis has been of considerable interest in recent years, as the natural mixture of isomers is not an economical source for the required C16’S, C14’R stereochemistry of biologically active vinblastine. Initially, the approach depends upon an enantioselective Sharpless epoxidation, which sets the stereochemistry at C20. The desired configuration around C16 and C14 can then be fixed during the ensuing steps. In this pathway, vinblastine is constructed by a series of cyclization and coupling reactions which create the required stereochemistry. The overall yield may be as great as 22%, which makes this synthetic approach more attractive than extraction from natural sources, whose overall yield is about 10%.[15] Stereochemistry is controlled through a mixture of chiral agents (Sharpless catalysts), and reaction conditions (temperature, and selected enantiopure starting materials).[16]
History[edit]
Vinblastine was first isolated by Robert Noble and Charles Thomas Beer at the University of Western Ontario from the Madagascar periwinkle plant. Vinblastine's utility as a chemotherapeutic agent was first suggested by its effect on the body when an extract of the plant was injected in rabbits to study the plant's supposed anti-diabetic effect. (A tea made from the plant was a folk-remedy for diabetes.) The rabbits succumbed to a bacterial infection, due to a decreased number of white blood cells, so it was hypothesized that vinblastine might be effective against cancers of the white blood cells such as lymphoma.[17]
References[edit]
^ Jump up to:a b c d e f g h i j "Vinblastine Sulfate". The American Society of Health-System Pharmacists. Archived from the original on 2015-01-02. Retrieved Jan 2, 2015.
^ Jump up to:a b Ravina E (2011). The evolution of drug discovery : from traditional medicines to modern drugs (1. Aufl. ed.). Weinheim: Wiley-VCH. p. 157. ISBN 9783527326693. Archived from the original on 2017-08-01.
^ Liljefors T, Krogsgaard-Larsen P, Madsen U (2002). Textbook of Drug Design and Discovery (Third ed.). CRC Press. p. 550. ISBN 9780415282888. Archived from the original on 2016-12-20.
^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
^ "Vinblastine sulfate- vinblastine sulfate injection". DailyMed. 31 December 2019. Retrieved 15 April 2020.
^ van Der Heijden R, Jacobs DI, Snoeijer W, Hallard D, Verpoorte R (March 2004). "The Catharanthus alkaloids: pharmacognosy and biotechnology". Current Medicinal Chemistry. 11 (5): 607–28. doi:10.2174/0929867043455846. PMID 15032608.
^ Cooper R, Deakin JJ (2016). "Africa's gift to the world". Botanical Miracles: Chemistry of Plants That Changed the World. CRC Press. pp. 46–51. ISBN 9781498704304. Archived from the original on 2017-08-01.
^ Keglevich P, Hazai L, Kalaus G, Szántay C (May 2012). "Modifications on the basic skeletons of vinblastine and vincristine". Molecules. 17 (5): 5893–914. doi:10.3390/molecules17055893. PMC 6268133. PMID 22609781.
^ Sears JE, Boger DL (March 2015). "Total synthesis of vinblastine, related natural products, and key analogues and development of inspired methodology suitable for the systematic study of their structure-function properties". Accounts of Chemical Research. 48 (3): 653–62. doi:10.1021/ar500400w. PMC 4363169. PMID 25586069.
^ Altmann K (2009). "Preclinical Pharmacology and Structure-Activity Studies of Epothilones". In Mulzer JH (ed.). The Epothilones: An Outstanding Family of Anti-Tumor Agents: From Soil to the Clinic. Springer Science & Business Media. pp. 157–220. ISBN 9783211782071. Archived from the original on 2017-09-11.
^ Starling D (January 1976). "Two ultrastructurally distinct tubulin paracrystals induced in sea-urchin eggs by vinblastine sulphate" (PDF). Journal of Cell Science. 20 (1): 79–89. PMID 942954. Archived (PDF) from the original on 2014-01-13.
^ Gobbi PG, Broglia C, Merli F, Dell'Olio M, Stelitano C, Iannitto E, et al. (December 2003). "Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi". Cancer. 98 (11): 2393–401. doi:10.1002/cncr.11807. hdl:11380/4847. PMID 14635074. S2CID 21376280.
^ Jordan MA, Wilson L (April 2004). "Microtubules as a target for anticancer drugs". Nature Reviews. Cancer. 4 (4): 253–65. doi:10.1038/nrc1317. PMID 15057285. S2CID 10228718.
^ Yang H, Ganguly A, Cabral F (October 2010). "Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs". The Journal of Biological Chemistry. 285 (42): 32242–50. doi:10.1074/jbc.M110.160820. PMC 2952225. PMID 20696757.
^ Kuehne ME, Matson PA, Bornmann WG (1991). "Enantioselective Syntheses of Vinblastine, Leurosidine, Vincovaline, and 20'-epi-Vincovaline". Journal of Organic Chemistry. 56 (2): 513–528. doi:10.1021/jo00002a008.
^ Yokoshima S, Tokuyama H, Fukuyama T (2009). "Total Synthesis of (+)-Vinblastine: Control of the Stereochemistry at C18′". The Chemical Record. 10 (2): 101–118. doi:10.1002/tcr.200900025.
^ Noble RL, Beer CT, Cutts JH (December 1958). "Role of chance observations in chemotherapy: Vinca rosea". Annals of the New York Academy of Sciences. 76 (3): 882–94. Bibcode:1958NYASA..76..882N. doi:10.1111/j.1749-6632.1958.tb54906.x. PMID 13627916. S2CID 34879726.
External links[edit]
"Vinblastine". Drug Information Portal. U.S. National Library of Medicine.
hide
v
t
e
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
SPs/MIs
(M phase)
Block microtubule assembly
Vinca alkaloids (Vinblastine#
Vincristine#
Vindesine
Vinflunine§
Vinorelbine#)
Block microtubule disassembly
Taxanes (Cabazitaxel
Docetaxel#
Larotaxel
Ortataxel†
Paclitaxel#
Tesetaxel)
Epothilones (Ixabepilone)
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Dihydrofolate reductase inhibitor (Aminopterin
Methotrexate#
Pemetrexed
Pralatrexate)
Thymidylate synthase inhibitor (Pemetrexed
Raltitrexed)
Purine
Adenosine deaminase inhibitor (Pentostatin)
Halogenated/ribonucleotide reductase inhibitors (Cladribine
Clofarabine
Fludarabine)
Nelarabine
Thiopurine (Mercaptopurine#
Tioguanine#)
Pyrimidine
Thymidylate synthase inhibitor (Capecitabine#
Carmofur
Doxifluridine
Floxuridine
Fluorouracil#
Tegafur (+gimeracil/oteracil))
DNA polymerase inhibitor (Cytarabine#)
Ribonucleotide reductase inhibitor (Gemcitabine#)
Hypomethylating agent (Azacitidine
Decitabine)
Deoxyribonucleotide
Ribonucleotide reductase inhibitor (Hydroxycarbamide#)
Topoisomerase inhibitors
(S phase)
I
Camptotheca (Belotecan
Camptothecin
Cositecan†
Exatecan
Gimatecan
Irinotecan#
Lurtotecan‡
Rubitecan‡
Silatecan§
Topotecan)
II
Podophyllum (Etoposide#
Teniposide)
II+Intercalation
Anthracyclines (Aclarubicin
Amrubicin†
Daunorubicin#
Doxorubicin#
Epirubicin
Idarubicin
Pirarubicin
Valrubicin
Zorubicin)
Anthracenediones (Mitoxantrone
Losoxantrone
Pixantrone)
Crosslinking of DNA
(CCNS)
Alkylating
Nitrogen mustards: Bendamustine#
Chlormethine
Cyclophosphamide# (Ifosfamide#
Trofosfamide)
Chlorambucil# (Melphalan
Prednimustine)
Uramustine
Nitrosoureas: Carmustine
Fotemustine
Lomustine (Semustine)
Nimustine
Ranimustine
Streptozocin
Alkyl sulfonates: Busulfan (Mannosulfan
Treosulfan)
Aziridines: Carboquone
Thiotepa
Triaziquone
Triethylenemelamine
Platinum-based
Carboplatin#
Cisplatin#
Dicycloplatin
Nedaplatin
Oxaliplatin#
Satraplatin
Nonclassical
Altretamine
Hydrazines]/blue] (Procarbazine#)
Mitobronitol
Pipobroman
Triazenes (Dacarbazine#
Temozolomide)
Intercalation
Streptomyces (Actinomycin#
Bleomycin#
Mitomycins
Plicamycin)
Photosensitizers/PDT
Aminolevulinic acid / Methyl aminolevulinate
Efaproxiral
Padeliporfin
Porphyrin derivatives (Porfimer sodium
Talaporfin
Temoporfin
Verteporfin)
Other
Enzyme inhibitors
FI (Tipifarnib§)
CDK inhibitors (Abemaciclib
Alvocidib†
Palbociclib
Ribociclib
Seliciclib†)
PrIBortezomib
Carfilzomib
Oprozomib
Ixazomib

PhI (Anagrelide)
IMPDI (Tiazofurin§)
LI (Masoprocol)
PARP inhibitor (Niraparib
Olaparib
Rucaparib)
HDAC (Belinostat
Panobinostat
Romidepsin
Vorinostat)
PIKI (Alpelisib
Idelalisib)
Receptor antagonists
ERA (Atrasentan)
Retinoid X receptor (Bexarotene)
Sex steroid (Testolactone)
Other/ungrouped
Amsacrine
Arsenic trioxide
Asparagine depleters (Asparaginase#/Pegaspargase)
Celecoxib
Demecolcine
Elesclomol§
Elsamitrucin
Eribulin
Estramustine phosphate
Etoglucid
Lonidamine
Lucanthone
Mitoguazone
Mitotane
Oblimersen†
Omacetaxine mepesuccinate
Trabectedin
Retinoids (Alitretinoin
Tretinoin#)
Venetoclax
#WHO-EM
‡Withdrawn from market
Clinical trials:†Phase III
§Never to phase III

📷Medicine portal
Categories:
Vinca alkaloids
Microtubule inhibitors
Mitotic inhibitors
Acetate esters
World Health Organization essential medicines
Navigation menu
Not logged in
Talk
Contributions
Create account
Log in
Article
Talk
Read
Edit
View history
Search
Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
Contribute
Help
Learn to edit
Community portal
Recent changes
Upload file
Tools
What links here
Related changes
Special pages
Permanent link
Page information
Cite this page
Wikidata item
Print/export
Download as PDF
Printable version
In other projects
Wikimedia Commons
Languages
العربية
Deutsch
Español
Français
日本語
Português
Русский
Tiếng Việt
中文
14 more
Edit links
This page was last edited on 2 December 2020, at 22:20 (UTC).
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia FoundatiON

Съдържаниет е скрито
Влезте за да го видите